- Home
- VLTO vs ILMN Comparison
VLTO vs ILMN Comparison
Compare VLTO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLTO
- ILMN
- Stock Information
- Founded
- VLTO 2023
- ILMN 1998
- Country
- VLTO United States
- ILMN United States
- Employees
- VLTO N/A
- ILMN N/A
- Industry
- VLTO Electrical Products
- ILMN Medical Specialities
- Sector
- VLTO Industrials
- ILMN Health Care
- Exchange
- VLTO Nasdaq
- ILMN Nasdaq
- Market Cap
- VLTO 25.1B
- ILMN 13.1B
- IPO Year
- VLTO N/A
- ILMN 2000
- Fundamental
- Price
- VLTO $103.35
- ILMN $96.14
- Analyst Decision
- VLTO Buy
- ILMN Buy
- Analyst Count
- VLTO 10
- ILMN 17
- Target Price
- VLTO $110.10
- ILMN $124.35
- AVG Volume (30 Days)
- VLTO 1.2M
- ILMN 2.4M
- Earning Date
- VLTO 07-28-2025
- ILMN 07-31-2025
- Dividend Yield
- VLTO 0.43%
- ILMN N/A
- EPS Growth
- VLTO 8.36
- ILMN N/A
- EPS
- VLTO 3.50
- ILMN N/A
- Revenue
- VLTO $5,279,000,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- VLTO $6.32
- ILMN N/A
- Revenue Next Year
- VLTO $4.80
- ILMN $3.15
- P/E Ratio
- VLTO $29.37
- ILMN N/A
- Revenue Growth
- VLTO 4.70
- ILMN N/A
- 52 Week Low
- VLTO $83.87
- ILMN $68.70
- 52 Week High
- VLTO $115.00
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- VLTO 60.31
- ILMN 55.14
- Support Level
- VLTO $99.57
- ILMN $95.75
- Resistance Level
- VLTO $102.53
- ILMN $99.78
- Average True Range (ATR)
- VLTO 1.71
- ILMN 3.15
- MACD
- VLTO -0.02
- ILMN -0.65
- Stochastic Oscillator
- VLTO 83.81
- ILMN 24.97
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.